Her kan du finde en oversigt over publikationer fra medlemmer af REPAIRkuben.
Terp, S. K., Stoico, M. P., Dybkær, K., & Pedersen, I. S. (2023). Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review. Clinical epigenetics, 15(1), 24. PMID:36788585
Ladekarl, M., Nøhr, A. K., Sønderkær, M., Dahl, S. C., Sunde, L., Vestereghem, C., Mapendano, C. K., Haslund, C. A., Pagh, A., Carus, A., Lörincz, T., Nowicka-Matus, K., Poulsen, L. Ø., Laursen, R. J., Dybkær, K., Poulsen, B. K., Frøkjær, J. B., Brügmann, A. H., Ernst, A., Wanders, A., … Pedersen, I. S. (2023). Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital. Acta oncologica (Stockholm, Sweden), 62(3), 261–271. PMID:36905645
Kringelbach, T., Højgaard, M., Rohrberg, K., Spanggaard, I., Laursen, B. E., Ladekarl, M., Haslund, C. A., Harsløf, L., Belcaid, L., Gehl, J., Søndergaard, L., Eefsen, R. L., Hansen, K. H., Kodahl, A. R., Jensen, L. H., Holt, M. I., Oellegaard, T. H., Yde, C. W., Ahlborn, L. B., & Lassen, U. (2023). ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial. BMC cancer, 23(1), 182. PMID:36814246
Schmidt, L., Issa, I. I., Haraldsdóttir, H., Hald, J. L., Schmitz, A., Due, H., & Dybkær, K. (2022). Hsp90 inhibition sensitizes DLBCL cells to cisplatin. Cancer chemotherapy and pharmacology, 89(4), 431–440. PMID:35190872